| Identification | Back Directory | [Name]
2-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxamide | [CAS]
902523-58-4 | [Synonyms]
ML261
2-chloro-N-[2-(3,4-diethoxyphenyl)ethyl]-4-methylthieno[3,2-b]pyrrole-5-carboxamide
2-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxamide
4H-Thieno[3,2-b]pyrrole-5-carboxamide, 2-chloro-N-[2-(3,4-diethoxyphenyl)ethyl]-4-methyl- | [Molecular Formula]
C20H23ClN2O3S | [MDL Number]
MFCD14786336 | [MOL File]
902523-58-4.mol | [Molecular Weight]
406.93 |
| Chemical Properties | Back Directory | [Boiling point ]
625.4±55.0 °C(Predicted) | [density ]
1.28±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: soluble5mg/mL, clear (warmed) | [form ]
powder | [pka]
14.14±0.46(Predicted) | [color ]
white to beige |
| Hazard Information | Back Directory | [Description]
ML-261 is a thienopyrrole-5-carboxamide that inhibits lipid droplet formation in murine AML12 hepatocytes (IC50 = 69.7 nM) but not in human Huh7 hepatocellular carcinoma or primary hepatocyte cells. | [Uses]
ML-261 is a thienopyrrole-5-caboxamide compound that inhibits hepatic lipid droplet formation. | [References]
[1] FUJIMOTO T, OHSAKI Y, SUZUKI M. Mechanism of Lipid Droplet Formation[C]. 1900: 0. DOI: 10.5360/membrane.33.17 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|